Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey
暂无分享,去创建一个
N. Kuriyama | A. Uzawa | S. Kuwabara | I. Nakashima | J. Fujimori | Yasunori Sato | Kengo Nagashima | Masashi Nakamura | R. Ogawa
[1] S. Mariotto,et al. Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy. , 2022, Multiple sclerosis and related disorders.
[2] F. Palavra,et al. Neuromyelitis optica spectrum disorders: A nationwide Portuguese clinical epidemiological study. , 2021, Multiple sclerosis and related disorders.
[3] K. Fujihara,et al. Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder , 2021, Neurology.
[4] B. Hemmer,et al. Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients , 2021, Multiple sclerosis journal - experimental, translational and clinical.
[5] Y. Sakai,et al. A nation-wide survey of Japanese pediatric MOG antibody-associated diseases , 2021, Brain and Development.
[6] K. P. Yong,et al. Central nervous system inflammatory demyelinating diseases and neuroimmunology in Singapore—Epidemiology and evolution of an emerging subspecialty , 2021 .
[7] M. Tintoré,et al. Clinical features and risk of relapses in children and adults with MOGAD. , 2020, Annals of neurology.
[8] Jacqueline Palace,et al. Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[9] K. Fujihara,et al. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. , 2020, Brain : a journal of neurology.
[10] S. Kuwabara,et al. Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey , 2019, Neurology.
[11] T. Siepman,et al. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults , 2019, Multiple sclerosis.
[12] J. Mills,et al. A multicenter comparison of MOG-IgG cell-based assays , 2019, Neurology.
[13] M. Reindl,et al. Myelin oligodendrocyte glycoprotein antibodies in neurological disease , 2018, Nature Reviews Neurology.
[14] R. Alroughani,et al. Pediatric multiple sclerosis: a review , 2018, BMC Neurology.
[15] X. Montalban,et al. Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates , 2018, Multiple sclerosis.
[16] Jacqueline Palace,et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study , 2017, Brain : a journal of neurology.
[17] K. Rostásy,et al. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome , 2017, Neurology.
[18] K. Fujihara,et al. MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy , 2017, Neurology: Neuroimmunology & Neuroinflammation.
[19] F. Paul,et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome , 2016, Journal of Neuroinflammation.
[20] A. Traboulsee,et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2015, Neurology.
[21] A. Straube,et al. Histopathology and clinical course of MOG-antibody-associated encephalomyelitis , 2015, Annals of clinical and translational neurology.
[22] Zhengqi Lu,et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders , 2014, Neurology.
[23] Huidy Shu,et al. Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis , 2014, Annals of neurology.
[24] A. Ghezzi,et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions , 2013, Multiple sclerosis.
[25] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[26] A. Bar-Or,et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein , 2007, Nature Medicine.